Please assess the completion status of the following clinical trial:

Trial Title: Observational Study on Efficacy and Safety of Liraglutide in Subjects With Type 2 Diabetes

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients diagnosed with type 2 diabetes~* Patients having recently started (for less than one week) or starting liraglutide (Victoza®) treatment~Exclusion Criteria:~* Hypersensitivity (allergy) to liraglutide or to any of the excipients~* Patient is participating in a clinical trial at the inclusion~* Type 1 diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- A (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).